VoxelCloud offers healthcare providers automated medical image analytics powered by AI, assisting in the diagnosis of conditions such as lung cancer, retinal diseases, and coronary heart disease, with plans to expand this list in the future.
Since its launch in 2016, VoxelCloud has primarily focused on the Chinese healthcare market, as indicated by its offices in China and major investors like Shenzhen Hongtai Capital Management Group, Quingsong Fund, and Hanfor Capital Management.
Now, with a leadership change and preparations for US clinical trials, VocxelCloud is poised for expansion into the American market. By leveraging its successes in China, the company aims to enhance its product offerings and broaden its reach in AI-assisted medical diagnostics.
Kirsty
Company Specialist at Welcome to the Jungle